SCHEMBL6424581

SCHEMBL6424581

CCC(O)Cc1ccccc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.42
NR3C1 P04150 1/20 0.42
PGR P06401 1/20 0.42
NR3C2 P08235 1/20 0.42
PPARG P37231 2/20 0.40
PPARA Q07869 1/20 0.40
SHBG P04278 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.39
DNM1 Q05193 1/20 0.39
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
SLC6A3 Q01959 1/20 0.37
KCNH2 Q12809 1/20 0.37
TRPA1 O75762 1/20 0.37
HPGD P15428 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8349103 1.00 TAAR1 (0.42) TAAR1NR3C1PGRNR3C2PPARG
SCHEMBL14402393 0.84 TAAR1 (0.39) TAAR1NR3C1PGRNR3C2PPARG
SCHEMBL6047669 0.84 TAAR1 (0.39) TAAR1NR3C1PGRNR3C2PPARG
SCHEMBL13849916 0.84 TAAR1 (0.39) TAAR1NR3C1PGRNR3C2PPARG
SCHEMBL27531705 0.83 CYP1A2 (0.50) TAAR1PPARGPPARALMNADNM1
SCHEMBL8418317 0.83 CYP1A2 (0.50) TAAR1PPARGPPARALMNADNM1
SCHEMBL15319160 0.82 TAAR1 (0.38) TAAR1PPARGPPARADNM1SLC6A2
SCHEMBL15319376 0.82 TAAR1 (0.42) TAAR1PPARGPPARAKMT2ALMNA
SCHEMBL11538150 0.82 TAAR1 (0.50) TAAR1PPARGPPARAKMT2ADNM1
SCHEMBL15319281 0.81 TAAR1 (0.37) TAAR1PPARGPPARADNM1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115672296-B Preparation and application of phenylalanine modified short-chain column [5] arene chiral chromatographic packing 中国科学院兰州化学物理研究所 2024-01-26 CN claimed
CN-115672296-B Preparation and application of phenylalanine modified short-chain column [5] arene chiral chromatographic packing 中国科学院兰州化学物理研究所 2024-01-26 CN disclosed
CN-115672296-B Preparation and application of phenylalanine modified short-chain column [5] arene chiral chromatographic packing 中国科学院兰州化学物理研究所 2024-01-26 CN disclosed
EP-2834233-B1 NEW ALPHA2 ADRENOCEPTOR AGONISTS ORION CORP (FI) 2018-04-25 EP disclosed
EP-2834233-B1 NEW ALPHA2 ADRENOCEPTOR AGONISTS ORION CORP (FI) 2018-04-25 EP disclosed
US-9249127-B2 Alpha2 adrenoceptor agonists ORION CORPORATION (FI) 2016-02-02 US disclosed
US-9249127-B2 Alpha2 adrenoceptor agonists ORION CORPORATION (FI) 2016-02-02 US disclosed
US-9249127-B2 Alpha2 adrenoceptor agonists ORION CORPORATION (FI) 2016-02-02 US disclosed
US-20150065550-A1 NEW ALPHA2 ADRENOCEPTOR AGONISTS ORION CORPORATION (FI) 2015-03-05 US disclosed
US-20150065550-A1 NEW ALPHA2 ADRENOCEPTOR AGONISTS ORION CORPORATION (FI) 2015-03-05 US disclosed
US-20150065550-A1 NEW ALPHA2 ADRENOCEPTOR AGONISTS ORION CORPORATION (FI) 2015-03-05 US disclosed
EP-2834233-A1 NEW ALPHA2 ADRENOCEPTOR AGONISTS Orion Corporation (FI) 2015-02-11 EP disclosed
WO-2013150173-A1 NEW ALPHA2 ADRENOCEPTOR AGONISTS ORION CORPORATION (FI) 2013-10-10 WO disclosed
EP-1527050-A1 QUINOLINE DERIVATIVES AND THEIR USE AS MYCOBACTERIAL INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-05-04 EP disclosed
WO-2004011436-A1 QUINOLINE DERIVATIVES AND THEIR USE AS MYCOBACTERIAL INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2004-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150065550-A1 NEW ALPHA2 ADRENOCEPTOR AGONISTS ADRA2A, ADRB2, ADRA2C TAAR1 75/4885NR3C1 516/4885PGR 1314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.